VSIR and melanoma: Le Mercier and colleagues showed that disrupting VISTA:PSGL-1 interactions with monoclonal antibodies enhanced the anti-tumor function of adoptively transferred T cells in mouse models of colorectal adenocarcinoma and melanoma [44].